Article Image

IPFS News Link • Pandemic

Vaccine for major common cold virus could be ready for use by 2024

• arclein

Several RSV vaccines are being tested in clinical trials, including one made by German company Bavarian Nordic. Its vaccine is designed to build immunity against RSV by exposing the body to five small fragments of the virus. In a clinical trial involving 420 adults aged 55 and older, a single injection of the vaccine in the upper arm tripled the levels of RSV-fighting antibodies inside the nose and caused no serious side effects.


PirateBox.info